OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
TechCrunch AI Marina Temkin
Miles Wang, an OpenAI researcher specializing in AI for scientific discovery, is leaving to start a drug discovery startup with several other OpenAI researchers. The new company is in funding discussions with Lightspeed to raise $200 million at a $2 billion valuation. The startup would focus on developing AI models to identify new uses for existing drugs, potentially reducing time to market compared to discovering entirely new treatments.
Why it matters
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
